REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |
| MPM BioImpact LLC | 273,408 | $7,567,933 | 2.02% |
| Integral Health Asset Management, LLC | 525,000 | $14,532,000 | 2.01% |
| Frazier Life Sciences Management, L.P. | 997,455 | $27,609,554 | 1.83% |
| Perceptive Advisors | 1,321,795 | $36,587,286 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,751,496 | $48,481,409 | 1.07% |
| Woodline Partners LP | 3,145,445 | $87,065,918 | 1.02% |
| Logos Global Management LP | 250,000 | $6,920,000 | 0.92% |
| SECTORAL ASSET MANAGEMENT INC | 142,650 | $3,948,552 | 0.77% |
| Avidity Partners Management LP | 657,200 | $18,191,296 | 0.73% |
| Ikarian Capital, LLC | 2,035 | $5,632,880 | 0.68% |
External links
This page lists REVOLUTION MEDICINES INC's shareholders in Q3 2023. To view REVOLUTION MEDICINES INC's shareholder history, click here.